EP0997143A3 - Weiche Kautablette - Google Patents
Weiche Kautablette Download PDFInfo
- Publication number
- EP0997143A3 EP0997143A3 EP99306455A EP99306455A EP0997143A3 EP 0997143 A3 EP0997143 A3 EP 0997143A3 EP 99306455 A EP99306455 A EP 99306455A EP 99306455 A EP99306455 A EP 99306455A EP 0997143 A3 EP0997143 A3 EP 0997143A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- chewable tablets
- soft chewable
- compressed
- disintegratable
- hardness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007910 chewable tablet Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 229940068682 chewable tablet Drugs 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/135,723 US6270790B1 (en) | 1998-08-18 | 1998-08-18 | Soft, convex shaped chewable tablets having reduced friability |
| US135723 | 1998-08-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP0997143A2 EP0997143A2 (de) | 2000-05-03 |
| EP0997143A3 true EP0997143A3 (de) | 2001-11-14 |
| EP0997143B1 EP0997143B1 (de) | 2007-12-19 |
Family
ID=22469364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99306455A Expired - Lifetime EP0997143B1 (de) | 1998-08-18 | 1999-08-17 | Weiche Kautablette |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6270790B1 (de) |
| EP (1) | EP0997143B1 (de) |
| JP (1) | JP2000095673A (de) |
| KR (1) | KR20000017352A (de) |
| CN (1) | CN1249176A (de) |
| AR (1) | AR022065A1 (de) |
| AT (1) | ATE381320T1 (de) |
| AU (1) | AU773549B2 (de) |
| BR (1) | BR9903736A (de) |
| CA (1) | CA2280628C (de) |
| CO (1) | CO5130019A1 (de) |
| DE (1) | DE69937780T2 (de) |
| ES (1) | ES2299234T3 (de) |
| NZ (1) | NZ337310A (de) |
| PT (1) | PT997143E (de) |
| SA (1) | SA99200655B1 (de) |
| ZA (1) | ZA995248B (de) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
| US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| US20020122823A1 (en) * | 2000-12-29 | 2002-09-05 | Bunick Frank J. | Soft tablet containing dextrose monohydrate |
| CA2447693A1 (en) * | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
| US7014867B2 (en) * | 2001-06-28 | 2006-03-21 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
| US20030060422A1 (en) * | 2001-08-31 | 2003-03-27 | Balaji Venkataraman | Tannate compositions and methods of treatment |
| US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
| NZ532096A (en) | 2001-09-28 | 2006-10-27 | Mcneil Ppc Inc | Dosage forms having an inner core and outer shell with different shapes |
| US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
| US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
| KR100446153B1 (ko) * | 2001-10-24 | 2004-08-30 | 한국유나이티드제약 주식회사 | 가용화된 이부프로펜 함유 제제의 조성물 및 그의 제조방법 |
| FR2831820B1 (fr) * | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| FR2833173B1 (fr) * | 2001-12-10 | 2004-08-27 | Roquette Freres | Preparation antipyretique renfermant du xylitol |
| WO2003080023A2 (en) * | 2002-03-20 | 2003-10-02 | Elan Pharma International Limited | Fast dissolving dosage forms having reduced friability |
| ATE388693T1 (de) | 2002-04-04 | 2008-03-15 | Pfizer Prod Inc | Wohlschmeckende kautablette |
| CA2497452C (en) | 2002-08-13 | 2013-09-24 | Akzo Nobel N.V. | Compositions and process for delivering an additive |
| BR0315942A (pt) | 2002-11-27 | 2005-10-04 | Dmi Biosciences Inc | Tratamento de doenças e condições mediadas pelo aumento de fosforilação |
| US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
| US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| EP1660104B1 (de) * | 2003-08-26 | 2010-03-10 | Shire Holdings AG | Pharmazeutische formulierung mit lanthanum-verbindungen |
| US7282217B1 (en) * | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
| CA2538352A1 (en) * | 2003-09-25 | 2005-04-07 | Dmi Biosciences Inc. | Methods and products which utilize n-acyl-l-aspartic acid |
| US20050095300A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
| US20050095299A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
| US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
| US20050226908A1 (en) * | 2004-04-07 | 2005-10-13 | Akzo Nobel N.V. | Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| JP5607291B2 (ja) | 2004-11-24 | 2014-10-15 | メダ ファーマシューティカルズ インコーポレイテッド | アゼラスチンを含む組成物およびその使用方法 |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| CN1686089B (zh) * | 2005-05-08 | 2010-08-18 | 北京健健康康生物技术有限公司 | 一种可直接压片的木糖醇颗粒及其制备方法 |
| EP1905430A4 (de) * | 2005-07-08 | 2012-08-01 | Takeda Pharmaceutical | Tablette |
| US20070020186A1 (en) * | 2005-07-22 | 2007-01-25 | Alpex Pharma S.A. | Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
| US20070128251A1 (en) * | 2005-12-07 | 2007-06-07 | Piedmont Pharmaceuticals, Inc. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| GB0601498D0 (en) | 2006-01-25 | 2006-03-08 | Probio Nutraceuticals As | Product |
| ZA200807571B (en) | 2006-03-01 | 2009-08-26 | Ethypharm Sa | Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion |
| US20070251352A1 (en) * | 2006-05-01 | 2007-11-01 | Pruitt Judith G | Pelletized Feed Material for Biomass Generator |
| WO2007144902A1 (en) * | 2006-06-12 | 2007-12-21 | Jubliant Organosys Limited | Chewable bilayer tablet formulation |
| US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| KR101109633B1 (ko) | 2007-08-03 | 2012-01-31 | 제이더블유중외제약 주식회사 | 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물 |
| USD616032S1 (en) * | 2007-08-24 | 2010-05-18 | Maraia Micah L | Clip for identifying elongated objects |
| ES2590604T3 (es) * | 2008-01-04 | 2016-11-22 | Schabar Research Associates Llc | Composición que comprende un analgésico y un antihistamínico |
| US20100009012A1 (en) * | 2008-07-11 | 2010-01-14 | Zukkoor N David | Chewable pharyngeal inflammation symptom relief composition |
| WO2010077878A1 (en) * | 2008-12-15 | 2010-07-08 | Fleming And Company, Pharmaceuticals | Rapidly dissolving vitamin formulation and methods of using the same |
| US20100278913A1 (en) * | 2009-04-30 | 2010-11-04 | Sancilio & Company | Chewable tablet |
| AU330360S (en) * | 2009-08-27 | 2010-04-14 | Astrazeneca Ab | Tablet |
| AU2010300641B2 (en) * | 2009-09-30 | 2016-03-17 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
| EP2509631A4 (de) * | 2009-12-10 | 2014-04-02 | Monosol Rx Llc | Ph-empfindliche verbindungen für eine geschmacksverbergung in oral einnehmbaren dünnschichtstreifen |
| USD636070S1 (en) * | 2010-02-26 | 2011-04-12 | Astrazeneca Ab | Tablet |
| USD632386S1 (en) * | 2010-06-01 | 2011-02-08 | Herbalife International of America | Oral supplement |
| JP5771381B2 (ja) * | 2010-10-22 | 2015-08-26 | アサヒフードアンドヘルスケア株式会社 | 乾燥酵母を含有する錠剤 |
| USD697510S1 (en) * | 2011-03-23 | 2014-01-14 | Brother Industries, Ltd. | Scanner with projector |
| WO2013037650A1 (fr) | 2011-09-15 | 2013-03-21 | Friulchem Spa | Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations |
| WO2013068371A1 (en) | 2011-11-08 | 2013-05-16 | Intervet International B.V. | Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists |
| LT2811998T (lt) | 2012-02-06 | 2019-02-25 | Merial, Inc. | Paraziticidinės peroralinės veterinarinės kompozicijos, apimančios sistemiškai veikiančius aktyviuosius agentus, būdai ir jų panaudojimas |
| EP2833866B2 (de) | 2012-04-04 | 2024-11-27 | Intervet International B.V. | Weiche, kaufähige pharmazeutische produkte |
| SI2861236T1 (sl) | 2012-06-15 | 2019-10-30 | Pharmathen Sa | Farmacevtski sestavek, ki vsebuje polimer, ki veže fosfat |
| CA2883139C (fr) | 2012-08-31 | 2021-08-10 | Friulchem Spa | Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations |
| US9532946B2 (en) * | 2012-11-20 | 2017-01-03 | Intervet Inc. | Manufacturing of semi-plastic pharmaceutical dosage units |
| MX366159B (es) | 2012-11-30 | 2019-07-01 | Acura Pharmaceuticals Inc | Liberacion autorregulada de ingrediente farmaceutico activo. |
| WO2015145461A1 (en) | 2014-03-26 | 2015-10-01 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release biphasic matrix solid dosage form |
| WO2016033424A1 (en) | 2014-08-29 | 2016-03-03 | Genzyme Corporation | Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b |
| CN104490804A (zh) * | 2014-12-05 | 2015-04-08 | 海南卫康制药(潜山)有限公司 | 一种西咪替丁组合物咀嚼片及其制备方法 |
| EP3061501A1 (de) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Zusammensetzung zur behandlung von akne |
| EP3117825A1 (de) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Orale formulierung mit berberin und morus-alba-extrakt |
| US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
| WO2017106812A1 (en) * | 2015-12-19 | 2017-06-22 | First Time Us Generics Llc | Soft-chew tablet pharmaceutical formulations |
| US20190022013A1 (en) | 2015-12-19 | 2019-01-24 | First Time Us Generics Llc | Soft-chew tablet pharmaceutical formulations |
| WO2017151571A1 (en) * | 2016-02-29 | 2017-09-08 | First Time Us Generics Llc | Abuse deterrent soft chewable drug formulations |
| BR112018073220A2 (pt) | 2016-05-12 | 2019-02-19 | Bayer Animal Health Gmbh | processo para preparar artigos conformados para administração a animais |
| US10323226B2 (en) | 2017-03-30 | 2019-06-18 | Nch Corporation | Feed material for biomass generator |
| WO2019004155A1 (ja) * | 2017-06-27 | 2019-01-03 | 第一三共株式会社 | 錠剤 |
| EP3878436A1 (de) | 2020-03-09 | 2021-09-15 | Bayer Animal Health GmbH | Weicher kaubarer formkörper zur verabreichung an tiere |
| KR20230051164A (ko) | 2020-07-15 | 2023-04-17 | 샤바르 리서치 어소시에이츠 엘엘씨 | 급성 통증의 치료 및 속쓰림의 중증도 및/또는 위험의 감소를 위한 이부프로펜 및 파모티딘으로 구성된 단위 경구 투여 조성물 |
| US12514846B2 (en) | 2020-07-15 | 2026-01-06 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach |
| US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| MX2023007150A (es) | 2020-12-18 | 2023-09-04 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de pirazol que contienen boro, composiciones que los comprenden, métodos y usos de los mismos. |
| IT202100016310A1 (it) * | 2021-06-22 | 2022-12-22 | Alaia Idea S R L | Metodo per la produzione di compresse |
| US20230123099A1 (en) * | 2021-10-15 | 2023-04-20 | Fertin Pharma A/S | Dextrose tablets with improved mouthfeel |
| US20240130974A1 (en) * | 2022-10-19 | 2024-04-25 | Genexa Inc. | Solid pharmaceutical tablet |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3431339A (en) * | 1966-07-20 | 1969-03-04 | Colgate Palmolive Co | Dentifrices |
| EP0180364A2 (de) * | 1984-10-16 | 1986-05-07 | Reckitt And Colman Products Limited | Phenothiazine enthaltende Arzneimittel |
| EP0196546A2 (de) * | 1985-03-25 | 1986-10-08 | Abbott Laboratories | Pharmazeutisches Tablettierverfahren |
| WO1991000096A1 (en) * | 1988-05-31 | 1991-01-10 | Amer Moh Samir | Low-dosage sublingual aspirin |
| WO1995000121A1 (en) * | 1993-06-18 | 1995-01-05 | Novo Nordisk A/S | Compressible enzyme powder |
| EP0636364A1 (de) * | 1993-07-27 | 1995-02-01 | McNEIL-PPC, INC. | Schnellauflösliche pharmazeutische Dosierungsformen und Verfahren zu ihrer Herstellung |
| EP0717986A1 (de) * | 1994-12-19 | 1996-06-26 | McNEIL-PPC, INC. | Rotogranulat und Beschichtung von Acetaminophen, Pseudoephedrin Chlorpheniramin und, gegebenenfalls, Dextromethorphan |
| US5536526A (en) * | 1988-01-11 | 1996-07-16 | Cultor Ltd. | Xylitol-based binding and diluting agent and a process for the production thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3619292A (en) * | 1968-07-15 | 1971-11-09 | Penick & Ford Ltd | Tablets and method of forming |
| US4760094A (en) * | 1986-10-21 | 1988-07-26 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
| US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
| US5275823A (en) * | 1989-04-27 | 1994-01-04 | Smith Kline & French Laboratories Ltd. | Pharmaceutical compositions |
| US5075114A (en) | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
| US5460825A (en) * | 1990-05-23 | 1995-10-24 | Mcneil-Ppc, Inc. | Taste mask coatings for preparing chewable pharmaceutical tablets |
| CA2068402C (en) | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
| US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
| US5609883A (en) | 1994-09-16 | 1997-03-11 | Advanced Technology Pharmaceuticals Corporation | Compressed tablet transitory lubricant system |
| US5686107A (en) * | 1995-01-30 | 1997-11-11 | Fmc Corporation | Chewable pharmaceutical tablets |
| DE69710460T2 (de) * | 1996-06-17 | 2002-10-02 | Janssen Pharmaceutica N.V., Beerse | Bikonvexe, rasch desintegrierende verabreichungsformen |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
-
1998
- 1998-08-18 US US09/135,723 patent/US6270790B1/en not_active Expired - Lifetime
-
1999
- 1999-08-17 ZA ZA9905248A patent/ZA995248B/xx unknown
- 1999-08-17 PT PT99306455T patent/PT997143E/pt unknown
- 1999-08-17 AT AT99306455T patent/ATE381320T1/de not_active IP Right Cessation
- 1999-08-17 KR KR1019990033896A patent/KR20000017352A/ko not_active Withdrawn
- 1999-08-17 ES ES99306455T patent/ES2299234T3/es not_active Expired - Lifetime
- 1999-08-17 EP EP99306455A patent/EP0997143B1/de not_active Expired - Lifetime
- 1999-08-17 DE DE69937780T patent/DE69937780T2/de not_active Expired - Lifetime
- 1999-08-17 CA CA002280628A patent/CA2280628C/en not_active Expired - Lifetime
- 1999-08-18 BR BR9903736-0A patent/BR9903736A/pt not_active Application Discontinuation
- 1999-08-18 JP JP11232034A patent/JP2000095673A/ja active Pending
- 1999-08-18 CN CN99119112A patent/CN1249176A/zh active Pending
- 1999-08-18 AU AU44565/99A patent/AU773549B2/en not_active Expired
- 1999-08-18 CO CO99052293A patent/CO5130019A1/es unknown
- 1999-08-18 AR ARP990104128A patent/AR022065A1/es not_active Application Discontinuation
- 1999-08-18 NZ NZ337310A patent/NZ337310A/xx unknown
- 1999-10-10 SA SA99200655A patent/SA99200655B1/ar unknown
-
2001
- 2001-06-13 US US09/880,179 patent/US6471991B2/en not_active Expired - Lifetime
-
2002
- 2002-08-22 US US10/226,540 patent/US7029699B2/en not_active Expired - Lifetime
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3431339A (en) * | 1966-07-20 | 1969-03-04 | Colgate Palmolive Co | Dentifrices |
| EP0180364A2 (de) * | 1984-10-16 | 1986-05-07 | Reckitt And Colman Products Limited | Phenothiazine enthaltende Arzneimittel |
| EP0196546A2 (de) * | 1985-03-25 | 1986-10-08 | Abbott Laboratories | Pharmazeutisches Tablettierverfahren |
| US5536526A (en) * | 1988-01-11 | 1996-07-16 | Cultor Ltd. | Xylitol-based binding and diluting agent and a process for the production thereof |
| WO1991000096A1 (en) * | 1988-05-31 | 1991-01-10 | Amer Moh Samir | Low-dosage sublingual aspirin |
| WO1995000121A1 (en) * | 1993-06-18 | 1995-01-05 | Novo Nordisk A/S | Compressible enzyme powder |
| EP0636364A1 (de) * | 1993-07-27 | 1995-02-01 | McNEIL-PPC, INC. | Schnellauflösliche pharmazeutische Dosierungsformen und Verfahren zu ihrer Herstellung |
| EP0717986A1 (de) * | 1994-12-19 | 1996-06-26 | McNEIL-PPC, INC. | Rotogranulat und Beschichtung von Acetaminophen, Pseudoephedrin Chlorpheniramin und, gegebenenfalls, Dextromethorphan |
Also Published As
| Publication number | Publication date |
|---|---|
| AR022065A1 (es) | 2002-09-04 |
| EP0997143A2 (de) | 2000-05-03 |
| EP0997143B1 (de) | 2007-12-19 |
| PT997143E (pt) | 2008-02-07 |
| JP2000095673A (ja) | 2000-04-04 |
| NZ337310A (en) | 2000-05-26 |
| ZA995248B (en) | 2001-02-19 |
| US7029699B2 (en) | 2006-04-18 |
| CN1249176A (zh) | 2000-04-05 |
| DE69937780T2 (de) | 2008-12-04 |
| SA99200655B1 (ar) | 2006-08-22 |
| US6471991B2 (en) | 2002-10-29 |
| US6270790B1 (en) | 2001-08-07 |
| AU4456599A (en) | 2000-03-09 |
| CA2280628A1 (en) | 2000-02-18 |
| ATE381320T1 (de) | 2008-01-15 |
| AU773549B2 (en) | 2004-05-27 |
| CA2280628C (en) | 2009-02-10 |
| BR9903736A (pt) | 2000-09-26 |
| DE69937780D1 (de) | 2008-01-31 |
| US20010043947A1 (en) | 2001-11-22 |
| ES2299234T3 (es) | 2008-05-16 |
| KR20000017352A (ko) | 2000-03-25 |
| US20030049316A1 (en) | 2003-03-13 |
| CO5130019A1 (es) | 2002-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0997143A3 (de) | Weiche Kautablette | |
| WO2000041681A3 (de) | ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN | |
| AU7451198A (en) | Solid pharmaceutical preparation | |
| CA2295035A1 (en) | Pharmaceutical formulations containing voriconazole | |
| ITRM920361A0 (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
| EP1813286A3 (de) | Pharmazeutische Zusammensetzung enthaltend eine Angiotensin-II antagonistisch wirkende Verbindung in Kombination mit einer anderen Verbindung | |
| ZA993338B (en) | Pharmaceutical formulations. | |
| ITRM920476A0 (it) | Formulazioni galeniche contenenti ciclosporina. | |
| EP1468679A3 (de) | Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe | |
| AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
| IL133397A (en) | Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin | |
| AU2845599A (en) | Pharmaceutical compositions and their use | |
| ZA996662B (en) | Active compound combinations having insecticidal and acaricidal properties. | |
| WO2000046359A3 (en) | Medicament | |
| WO2001072125A8 (de) | Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften | |
| ZA961138B (en) | Solid active ingredient compositions containing hydroxypropylcellulose. | |
| CA2106216A1 (en) | Chewable antacid compositions | |
| WO2000072820A3 (en) | Injectable anesthetic formulation | |
| CA2379314A1 (en) | Tablet for sucking, containing ambroxol | |
| IL148193A0 (en) | Hard candy with improved storage stability | |
| DE59001121D1 (en) | Antacidatabletten. | |
| CA2402708A1 (en) | Torasemide-containing pharmaceutical preparations | |
| WO2003020265A3 (en) | Compositions comprising pectin and ascorbic acid | |
| ATE201996T1 (de) | Hirudin enthaltende pharmazeutische zusammensetzungen | |
| MXPA00011043A (es) | Conjunto de punzon y punta de troquel mejorado para formar por compresion unidades de dosificacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17P | Request for examination filed |
Effective date: 20020424 |
|
| AKX | Designation fees paid |
Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20030825 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REF | Corresponds to: |
Ref document number: 69937780 Country of ref document: DE Date of ref document: 20080131 Kind code of ref document: P |
|
| REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20080125 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080319 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2299234 Country of ref document: ES Kind code of ref document: T3 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 |
|
| NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 |
|
| ET | Fr: translation filed | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20080814 Year of fee payment: 10 |
|
| 26N | No opposition filed |
Effective date: 20080922 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080320 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071219 |
|
| REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20100217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080817 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20150811 Year of fee payment: 17 Ref country code: IE Payment date: 20150810 Year of fee payment: 17 Ref country code: ES Payment date: 20150713 Year of fee payment: 17 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20150629 Year of fee payment: 17 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20150827 Year of fee payment: 17 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 69937780 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20170428 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170301 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160817 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160817 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160818 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20181121 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20180815 Year of fee payment: 20 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20190816 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190816 |